Researchers develop method to identify dormant cells that carry HIV
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Mirage News5h
New Method Identifies Dormant HIV-Carrying Cells
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
HIV's latent reservoir: New insights into Nef protein offer potential strategy to improve treatment
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Mirage News17h
Mount Sinai Unveils Method to Spot Dormant HIV Cells
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery ...
HIV Protection in One Injection? Gilead’s Lenacapavir Could Be a Game-Changer!
A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term protection, simplifying adherence, and expanding access to at-risk populations., Hea ...
Hope for HIV prevention: Annual injection completes important safety trial
However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...
PhillyVoice2h
MRNA vaccines, once a Trump boast, now face attacks from some in GOP
The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Company Achieves Key Clinical Milestone with more than 20 Patients Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20Pharmacodynamic ...
Le Lézard21h
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching
ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...
Antigenic variation: How pathogens control changes in their cell surface to evade the immune system
The immune system responds to an infection by producing antibodies that recognize and bind to the cell surface of the ...
North Country Public Radio20h
COVID is still evolving and will find new ways to evade immune systems, scientists say
SARS-CoV-2 has been evolving the ability to evade the immune system about twice as fast as the fastest-evolving flu virus. It averages more than a dozen significant changes every year.
Frontiers2h
Systems Approaches to Understanding Self-tolerance and Immunotherapy Responses
A cornerstone of the immune system is its ability to maintain self-tolerance. This defense network orchestrates effector responses against pathogenic ...